Background And Purpose: Mesenchymal stem cells (MSC) have been demonstrated to improve cardiac function via the secretion of paracrine factors rather than direct differentiation. We, therefore, investigated whether bone marrow-derived MSC (BMSC)-released exosomes (BMSC-exo) enhance neurological recovery in spontaneously hypertensive rats (SHR) with ischemic stroke.

Methods: Markers of BMSC and BMSC-exo were detected to characterize BMSC and BMSC-exo. A green fluorescent PKH-67-labeled assay was conducted to ensure BMSC-exo internalization. Rat neuronal cells (RNC) were induced with Ang II and oxygen-glucose deprivation. The protective effects of BMSC-exo on RNC were studied by CCK-8, LDH, and immunofluorescence assays. SHR were subjected to middle cerebral artery occlusion, and the systolic and diastolic blood pressure changes in the modeled rats were measured. The effects of BMSC-exo on SHR were investigated by mNSS scoring, foot-fault tests, immunohistochemistry, Western blot, TTC staining, TUNEL, and HE staining. The hub genes related to SHR and proteins shuttled by BMSC-exo were intersected to obtain a possible candidate, followed by rescue experiments.

Results: BMSC-exo significantly promoted RNC viability and repressed cell apoptosis and cytotoxicity. Moreover, SHR administrated with BMSC-exo exhibited significant improvement in functional recovery and narrowed infarct size. BMSC-exo shuttled the MYCBPAP protein. Knockdown of MYCBPAP inhibited the protective effects of BMSC-exo on RNC and exacerbated synaptic damage in SHR.

Conclusions: MYCBPAP shuttled by BMSC-exo facilitates synaptic remodeling in SHR, which may contribute to a therapeutic strategy for ischemic stroke treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchemneu.2023.102309DOI Listing

Publication Analysis

Top Keywords

bmsc-exo
12
effects bmsc-exo
12
mesenchymal stem
8
stem cells
8
synaptic remodeling
8
ischemic stroke
8
bmsc bmsc-exo
8
protective effects
8
bmsc-exo rnc
8
shuttled bmsc-exo
8

Similar Publications

Objective: Cholangiocarcinoma (CCA) presents a therapeutic challenge due to its aggressiveness and poor survival rates. This study introduces an approach using tissue inhibitor of metalloproteinase 2 (TIMP2)-enriched bone marrow mesenchymal stem cell-derived exosomes (BMSC-Exo) encapsulated in chitosan hydrogels (CS), intending to provide novel insight into the CCA treatment.

Methods: BMSC-Exo was characterized by using TEM, nanoparticle tracking analysis, and western blotting.

View Article and Find Full Text PDF

Osteoarthritis (OA) is the most prevalent chronic degenerative joint disease among the aged population. The primary objective of this study was to assess the therapeutic potential of puerarin loaded bone marrow mesenchymal stem cell-derived exosomes (Pue@BMSC-Exo), and reveal their inflammatory regulating mechanisms through affecting the nuclear factor kappa-B (NF-κB) signaling pathway. In this study, exosomes derived from BMSCs were isolated and identified.

View Article and Find Full Text PDF
Article Synopsis
  • Diabetic intracerebral hemorrhage (ICH) is a severe complication of diabetes, and this study explores how bone marrow mesenchymal stem cell-derived exosomes (BMSC-exo) affect neuroinflammation in diabetic patients post-ICH.
  • The research involves isolating and modifying BMSC-exo with microRNA-129-5p (miR-129-5p) and injecting them into diabetic mice with ICH to analyze their effects on inflammation and nerve function.
  • Results indicate that BMSC-exo enhance recovery from neuroinflammation, with miR-129-5p playing a key protective role by reducing inflammation and improving neurological outcomes in cases of concurrent diabetes and ICH.
View Article and Find Full Text PDF

Doxorubicin (DOX) is an important chemotherapeutic agent for the treatment of hematologic tumors and breast carcinoma. However, its clinical application is limited owing to severe cardiotoxicity. Pyroptosis is a form of programmed cell death linked to DOX-induced cardiotoxicity.

View Article and Find Full Text PDF

Myocardial ischemia/reperfusion injury (MIRI) is a significant challenge in the management of myocardial ischemic disease. Extensive evidence suggests that the macrophage‑mediated inflammatory response may play a vital role in MIRI. Mesenchymal stem cells and, in particular, exosomes derived from these cells, may be key mediators of myocardial injury and repair.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!